| abstract |
Methods and compositions for extending the half-life of therapeutic agents are provided. One or more half-life extending moieties can be attached to the therapeutic agent, thereby extending the half-life of the therapeutic agent. A modified therapeutic agent (mTA) comprising one or more half-life extending moieties attached to the therapeutic agent may be used to treat a disease or condition in a subject in need thereof. [Selection] Figure 1 |